Press Releases
Bimekizumab Demonstrated Sustained Clinical Responses to Week 52 in Phase 3 Studies in Psoriatic Arthritis, Non-Radiographic Axial Spondyloarthritis and Ankylosing Spondylitis
UCB, a global biopharmaceutical company, announced the first presentation of long-term, 52-week data from three Phase 3 studies evaluating the efficacy and safety of...
Press Releases
Clinerion launches its Federated Machine Learning Platform
Clinerion launches its Federated Machine Learning Platform, a global, federated machine learning (ML) platform on its Patient Network Explorer infrastructure, incorporating its global network...
Articles
Aiming for balance in a conflicted world
With sustainability as a daily challenge and energy in short supply, a dependable management plan is essential
If someone asks me today, “As an executive...
Drug Research
NHS Permits Potentially Life-Saving Breast Cancer Medicine
The confidential agreement reached by the NHS and the manufacturer is expected to assist up to 1,600 women annually who have high-risk, triple-negative breast...
Press Releases
UCB Reinforces Commitment to Rheumatology with 15 Abstracts including New Late-Breaking Data at ACR Convergence 2022
UCB, a global biopharmaceutical company, announced that it will present 15 abstracts across its rheumatology portfolio at ACR Convergence 2022 to be held in...
Press Releases
Quanticate announces plans to accelerate growth in North America
Quanticate, a global data-focused clinical research organisation (CRO), has announced plans for further expansion and new jobs in 2023 as it thrives post-pandemic.
The UK-headquartered...
Clinical Trials
Next ASH To Focus Bispecific Cancer Drugs And Gene Therapy
The 64th annual meeting of the American Society of Hematology, a prestigious venue for some of their field's most significant research, will be held...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read